mecA Gene Profile of Methicillin-Resistant Staphylococcus aureus Isolates from Clinical Sources in Port Harcourt, Nigeria
American Journal of Biomedical and Life Sciences
Volume 4, Issue 3, June 2016, Pages: 41-48
Received: Mar. 20, 2016; Accepted: Mar. 30, 2016; Published: May 13, 2016
Views 3408      Downloads 207
Authors
Easter Godwin Nwokah, Department of Medical Laboratory Science, Rivers State University of Science and Technology, Port Harcourt, Nigeria
Samuel Douglas Abbey, Department of Medical Laboratory Science, Rivers State University of Science and Technology, Port Harcourt, Nigeria
Confidence Kinikanwo Wachukwu, Department of Medical Laboratory Science, Rivers State University of Science and Technology, Port Harcourt, Nigeria
Article Tools
Follow on us
Abstract
Staphylococcus aureus strains are responsible for a range of acute to chronic infections in humans and other animals. There is scanty information about the genetic background of S. aureus strains in Rivers State, Nigeria. The aim of this study was to determine the occurrence of MRSA among S. aureus isolates as well as detect the presence of mecA gene among methicillin-resistant Staphylococcus aureus isolates in Port Harcourt, Nigeria. Two hundred and five (205) non duplicate Staphylococcus aureus previously isolated from human sources were randomly collected from three health facilities- University of Port Harcourt Teaching Hospital, Braithwaite Memorial Specialist Hospital and De-Integrated Laboratories- all located in Port Harcourt, Nigeria, for this study from August, 2012 to July, 2013. Isolates were grouped as hospital in-patient (Hospital-acquired – Nosocomial; n = 76) and out-patient cases (community-acquired; n = 129). Isolates were reconfirmed following standard laboratory protocols and stored in duplicate - one set at +4°C (for phenotypic detection of MRSA) and another set at -70°C for molecular analysis. Using the disk diffusion method, detection of MRSA was carried out with 1μg of oxacillin (OXOID) placed on Mueller-Hinton agar with 4% NaCl supplementation). Molecular Analyses were carried out on all ORSA strains as follows- Bacterial genomic DNA extraction and PCR amplification for detection of 16S rRNA and mecA genes. Amplified products were analyzed using 2.0% agarose gel electrophoresis and subsequently visualized on a UV trans-illuminator. About twelve percent (12.2%) of the 205 Staphylococcus aureus studied were resistant to oxacillin. MRSA detection was significantly higher in in-patient isolates (23.7% of 76) than out-patient (5.4% of 129) S. aureus (p = 0.00031). Urine samples accounted for majority of the isolates (52 of 205) but MRSA detection was highest in Wound swabs (9 of 48 isolates. Of the 25 MRSA, mecA gene was detected in 17, being significantly higher in in-patient MRSA (14) than out-patient MRSA (3) (p<0-05). This study has established the presence of the methicillin resistance encoding gene- mecA, among MRSA isolates in Port Harcourt and that this gene is largely responsible for the MRSA phenotype. Study further establishes that these MRSA are more frequent in the Hospital environment. Further studies on molecular epidemiology of S. aureus are recommended in this region. Improved infection control measures in the healthcare facilities as well as sustained surveillance of methicillin-resistant S. aureus in this region are also advocated.
Keywords
Staphylococcus aureus, MRSA, mecA Gene
To cite this article
Easter Godwin Nwokah, Samuel Douglas Abbey, Confidence Kinikanwo Wachukwu, mecA Gene Profile of Methicillin-Resistant Staphylococcus aureus Isolates from Clinical Sources in Port Harcourt, Nigeria, American Journal of Biomedical and Life Sciences. Vol. 4, No. 3, 2016, pp. 41-48. doi: 10.11648/j.ajbls.20160403.14
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Taiwo, S. S., Onile, B. A. and Akanbi-II, A. A. (2004). Methicillin-resistant Staphylococcus aureus isolates in Ilorin, Nigeria. African Journal of Clinical and Experimental Microbiology, 5(2), 189-197.
[2]
Kluytmans, J., Van Belkum, A. and Verbrugh, H. (1997). Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews, 10, 505-520.
[3]
Barber, M., and Rozwadowska-Dowzenko, M. (1948). Infection by penicillin-resistant staphylococci. Lancet, 2(6530), 641-644.
[4]
Shanson, D. C. (1981). Antibiotic-resistant Staphylococcus aureus. Journal of Hospital Infection, 2(1), 11-36.
[5]
Jensen, S. O. and Lyon, B. R. (2009). Genetics of Antimicrobial Resistance in Staphylococcus aureus. Future Microbiology, 4(5), 565-582.
[6]
Shittu, A. O., Okon, K., Adesida, S., Oyedara, O., Witte, W., Strommenger, B., Layer, F. and Nübel, U. (2011). Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BioMed Central Microbiology, 11, 92-99.
[7]
Abbey, S. D., Nwokah, E. G., Obunge, O. K. and Wachukwu C. K. (2008). The Aetiology of Neonatal Septicaemia in Port Harcourt, Nigeria. Mary Slessor Journal of Medicine, 8(1), 27-31.
[8]
Nwokah, E. G. Obunge, O. K, Ayodele, M. B. O., Abbey, S. D. and Tatfeng, Y. M. (2012). Nasal Carriage of Staphylococcus aureus and MRSA among Food Handlers in a Sub-Urban Setting in Rivers State, Nigeria. Nigerian Biomedical Science Journal, 8 (3), 58–61.
[9]
Hartman, B. J. and Tomasz, A. (1984). Low-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. Journal of Bacteriology, 158(2), 513-516.
[10]
Matsuhashi, M., Song, M. D., Ishino, F. Wachi, M., Doi, M., Inoue, M. Ubukata, K., Yamashita, N. and Konno, M. (1986). Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to b-lactam antibiotics in Staphylococcus aureus. Journal of Bacteriology, 167, 975–980.
[11]
Montanari, M. P., Tonin, E., Biavasco, F. and Varaldo, P.E. (1990). Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins. Antimicrobial Agents and Chemotherapy, 34, 911–913.
[12]
de Lencastre, H. and Tomasz, A. (1994). Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 38, 2590–2598.
[13]
Saikia, L., Nath, R., Choudhury, B. and Sarkar, M. (2009). Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus. Asian Journal of Critical Care Medicine, 13(3), 156-158.
[14]
Tiemersma, E. W., Bronzwaer, S. L., Lyytikainen, O., Degener, J.E., Schrijnemakers, P., Bruinsma, N., Monen, J., Witte, W. and Grundmann, H. (2004). Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerging Infectious Diseases, 10, 1627-1634.
[15]
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan T. C. and Hughes, J. M. (1988). CDC definitions for nosocomial infections. American Journal of Infection Control, 16, 128-140.
[16]
Cheesbrough, M. (2000). District laboratory practice in tropical countries (2), Cambridge University press, UK.
[17]
Bauer, A. W., Kriby, W. M., Sherris, W. M. and Turk, J. C. (1966). Bauer-Kirby standardized, single disc susceptibility, test for rapid growing pathogens. American Journal of Clinical Pathology, 45, 493-498.
[18]
Clinical Laboratory Standards Institutes (2009). Performance Standards for Antimicrobials Susceptibility testing; Nineteenth informational supplement. m100-S19, 29(3).
[19]
Oviasogie, F. E. and Agbonlahor, D. E. (2013). The burden, antibiogram and pathogenicity of bacteria found in municipal waste dumpsites and on waste site workers in Benin City. Journal of Medicine and Biomedical Research, 12 (2), 115-130.
[20]
Bekibele, C. O., Kehinde, A. O. and Ajayi, B. G. (2009). Upper lid skin bacterial count of surgical eye patients in Ibadan, Nigeria. African Journal of Medical Science, 37, 273-277.
[21]
Onipede, A. O., Onayade, A. A., Elusiyan, J. B., Obiajunwa, P. O., Ogundare, E. O., Olaniran, O. O., Adeyemi, L. A. and Oyelami, O. O. (2009). Invasive bacterial isolates from children with severe infections in a Nigerian hospital. Journal of Infections in Developing Countries. 2, 429-436.
[22]
Shittu, A. O., Lin, J. and Kolawole, D. O. (2006). Antimicrobial susceptibility patterns of Staphylococcus aureus and characterization of MRSA in Southwestern Nigeria. Wounds, 18, 77-84.
[23]
Ghebremedhin, B., Olugbosi, M. O., Raji, A. M., Layer, F., Bakare, R. A., König, B. and König, W. (2009). Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. Journal of Clinical Microbiology, 47(9), 2975–2980.
[24]
Okon, K. O., Basset, P., Uba, A., Lin, J., Shittu, A. O. and Blanc, D. S. (2009). Co-occurrence of predominant Panton-Valentine leukocidin-positive sequence type (ST) 152 and multi-drug resistant ST241 Staphylococcus aureus clones in Nigerian hospitals. Journal of Clinical Microbiology, 47(9), 3000–3003.
[25]
Akanbi1, B. O. and Mbe1, J. U. (2013). Occurrence of methicillin and vancomycin resistant staphylococcus aureus in University of Abuja Teaching Hospital, Abuja, Nigeria. African Journal of Clinical and Experimental Microbiology, 14(1), 10-13.
[26]
Kesah, C., Ben Redjeb, S., Odugbemi, T. O., Boye, C. S., Dosso, M., Ndinya Achola, J. O., Koulla-Shiro, S., Benbachir, M., Rahal, K. and Borg, M. (2003): Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clinical Microbial Infections, 9, 153-156.
[27]
Debra, A. G. and Michael, J. D. (2007). Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobial. Journal of Medical Microbiology, 56, 1189-1195.
[28]
Olowe, O. A., Eniola, K. I. T., Olowe, R. A., and Olayemi, A. B. (2007). Antimicrobial Susceptibility and Beta-lactamase detection of MRSA in Osogbo. Southwest Nigeria. Nature and Science, 5(3), 44-48.
[29]
Terry-Alli, O. A., Ogbolu, D. O., Akorede, E., Onemu, O. M. and Okanlawon, B. M. (2011). Distribution of mec A gene amongst Staphylococcus aureus isolates from Southwestern Nigeria. African Journal of Biomedical Research, 14, 9-16.
[30]
Onanuga, A., Oyi, A. R., and Onaolapo, J. A. (2005). Prevalence and susceptibility pattern of methicillin resistant Staphylococcus aureus isolates among healthy women in Zaria, Nigeria. African Journal of Biotechnology, 4, 1321-1324.
[31]
Orji, I., Nworie, A., Eze, U. A., Agberotimi, I. O., Okereke, E. C. and Azi, S. O. (2012). The prevalence and antimicrobial susceptibility profile of methicillin-resistant Staphylococcus aureus from clinical specimens in tertiary hospital, South-East, Nigeria. Continental Journal of Pharmaceutical Science, 6(1), 23-29.
[32]
Mehta, A. P., Rodrigues, C., Sheth, K., Jani, S., Hakimiyan, A. and Fazalbhoy, N. (1998). Control of methicillin resistant Staphylococcus aureus in a tertiary care centre – A five year study. Journal of Medical Microbiology, 16, 31-34.
[33]
Denton, M., Connel, B. O., Bernard, P., Jarlier, V., Williams, Z. and Santerre, H. A. (2008). The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. Journal of Antimicrobial Chemotherapy, 61,586-588.
[34]
Derek F. J. Brown, David I. Edwards, Peter M. Hawkey, Donald Morrison, Geoffrey L. Ridgway, Kevin J. Towner and Michael W. D. (2005). Wren on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). Journal of Antimicrobial Chemotherapy, 56, 1000–1018.
[35]
Fridkin, S. K., Hageman, J. C. and Morrison, M. (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine, 352, 1436–1444.
[36]
Ikeh, E. I. (2003). Methicillin-resistant Staphylococcus aureus (MRSA) at Jos University Teaching Hospital. African Journal of Clinical and Experimental Microbiology, 4 (1), 52–55.
[37]
Nwakwo, B. O. K., Abdulhadi, S., Magagi, A. and Ihesiulor, G. (2010). Methicillin-resistant Staphylococcus aureus and their antibiotic susceptibility pattern in Kano, Nigeria. African Journal of Clinical and Experimental Microbiology, 11(1), 1595-689.
[38]
Brown, D. F. G. (2001). Detection of methicillin/oxacillin resistance in staphylococci. Journal of Antimicrobial Chemotherapy, 48(suppl S1), 65–70.
[39]
Aires de Sousa, M., Sanches, I. S., Ferro, M. L., Vaz, M. J., Saraiva, Z., Tendeiro, T., Serra, J. and de Lencastre, H. (1998). Intercontinental spread of a multidrug-resistant methicillin-resistant Staphylococcus aureus clone. Journal of Clinical Microbiology, 36, 2590-2596.
[40]
Snyder, J. W., Munier, G. K., Heckman, S. A., Camp, P. and Overman, T. L. (2009). Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. Journal of Clinical Microbiology, 47, 3747–3748.
[41]
Stamper, P. D., et al. (2011). Genotypic and phenotypic characterization of methicillin- susceptible Staphylococcus aureus isolates misidentified as methicillin- resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. Journal of Clinical Microbiology, 49, 1240–1244.
[42]
Qureshi, A., Ingle, R., Musaddiq, M., Ali, Y. and Khan, Z. (2012). Status and distribution of MECA gene in hospitalized patient’s MRSA isolates. Bioscience Discovery, 3(1), 52-57.
[43]
Martin-Lopez, J. V., Perez-Roth, E., Claverie-Martin, F., Diez Gil, O., Batista, N., Morales, M. and Mendez-Alvarez, S. (2002): Detection of Staphylococcus aureus Clinical Isolates Harboring the ica Gene Cluster Needed for Biofilm Establishment. Journal of Clinical Microbiology, 40, 1569-1570.
[44]
Adesida, S., Boelens, H., Babajide, B., Kehinde, A., Snijders, S., Van Leeuwen, W., Coker, A., Verbrugh, H. and Van Belkum, A. (2005). Major Epidemic Clones of Staphylococcus aureus in Nigeria. Microbial Drug Resistance, 11(2), 115 – 121.
[45]
Cramton, S. E., Gerke, C., Schnell, N. F., Nichols, W. W. and Gotz, F. (1999). The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infection and Immunity, 67, 5427-5433.
[46]
Memmi, G., Filipe, S. R., Pinho, M. G., Fu, Z. and Cheung, A. (2008). Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrobial Agents and Chemotherapy, 52, 3955-3966.
[47]
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D. et al. (2011). Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infectious Diseases, 11, 595–603.
[48]
Shore, A. C., Deasy, E. C., Slickers, P., Brennan, G., O’Connell, B., Monecke, S., Ehricht, R. and Coleman, D.C. (2011) Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 55, 3765–3773.
[49]
Paterson, G. K., Morgan, F. J. E., Harrison, E. M., Cartwright, E. J. P., Torok, M. E., Zadoks R. N., Parkhill J., Peacock S. J. and Holmes, M. A. (2014). Prevalence and characterization of human mecC methicillin-resistant Staphylococcus aureus isolates in England, Journal of Antimicrobial Chemotherapy, 69, 907–910.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186